ロード中...
Personalized one-two punches for lung cancer
Discovery of individualized therapies to address resistance to tyrosine kinase inhibitors (TKIs) has been hampered by the inability to test drug combinations on patient samples before and after TKI resistance. A recent study published in Science by Crystal et al. describes a methodology for pharmaco...
保存先:
出版年: | Cell Res |
---|---|
主要な著者: | , , |
フォーマット: | Artigo |
言語: | Inglês |
出版事項: |
Nature Publishing Group
2015
|
主題: | |
オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4349242/ https://ncbi.nlm.nih.gov/pubmed/25547118 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cr.2014.168 |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|